Kessler Investment Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-125
Closed -$14.2K 193
2024
Q2
$14.2K Sell
125
-37,933
-100% -$4.8M 0.01% 121
2024
Q1
$5.28M Buy
38,058
+972
+3% +$122K 3.27% 17
2023
Q4
$4.6M Sell
37,086
-1,202
-3% -$123K 2.82% 20
2023
Q3
$3.57M Buy
38,288
+1,198
+3% +$135K 2.99% 16
2023
Q2
$4.77M Buy
+37,090
New +$4.49M 3.35% 13
2015
Q3
Sell
-488
Closed -$10K 103
2015
Q2
$10K Buy
+488
New +$8.57K 0.02% 83
2015
Q1
Sell
-77,120
Closed -$1.06M 108
2014
Q4
$1.06M Sell
77,120
-332
-0.4% -$4.07K 1.74% 26
2014
Q3
$774K Buy
77,452
+76
+0.1% +$777 1.36% 31
2014
Q2
$767K Buy
77,376
+4,636
+6% +$41.1K 1.35% 31
2014
Q1
$752K Buy
+72,740
New +$752K 1.59% 26

Other funds holding DXCM

Kessler Investment Group's DXCM Position: Q3 2024 in Review

Kessler Investment Group sold out of DexCom (DXCM) in Q3 2024, closing a stake of 125 shares — an estimated $14.2K sold.

Kessler Investment Group first reported a position in DXCM in Q1 2014 and held it in 10 quarters. The position peaked at $5.28M in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Kessler Investment Group reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Kessler Investment Group sold 125 DexCom shares in Q3 2024, an estimated $14.2K.
  • Kessler Investment Group first reported a position in DexCom in Q1 2014 and held it in 10 quarters.
  • Kessler Investment Group's DexCom position peaked at $5.28M in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Kessler Investment Group's 13F filing for Q3 2024, filed 21 Oct 2024.